All companies
Visit website
PHIZZLE
OperatingPhizzle, Inc
Healthcare · Founded 2005
Data integrity for the pharmaceutical industry
Post-money valuation ⓘ
$78.4M
As of Mar 2023 · from PHIZZLE Common Stock 1 · pre-money + amount raised, not a traded price
Total raised
$141,858
Across 1 round since 2022
Latest share price
$0.40
PHIZZLE Common Stock 1 offering price
Financials
FY2020–FY2024 · from SEC filings · hover any figure for its source$1.4M
−$1.8M
2020
$869K
−$2.5M
2021
$480K
−$3.2M
2022
$621K
−$3.7M
2023
$624K
−$3.9M
2024
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020
FY2021
FY2022
FY2023
FY2024
Income statement
Revenue
$1,365,296
$869,326
$479,933
$620,976
$624,080
Cost of goods sold
$334,648
$507,569
$762,584
$632,391
$627,099
Gross margin
75%
42%
-59%
-2%
0%
Net income
-$1,765,819
-$2,454,298
-$3,201,325
-$3,660,847
-$3,946,654
Taxes paid
$0
$1,262
$2,973
$933
$0
Balance sheet
Cash
$722,081
$615,364
$414,344
$3,331,224
$218,187
Accounts receivable
$308,561
$24,218
$60,000
$0
$50,000
Total assets
$1,113,142
$724,602
$539,656
$3,572,567
$362,640
Short-term debt
$789,019
$3,145,772
$1,218,500
$617,295
$373,350
Long-term debt
$954,036
$141,228
$141,228
$369,204
$1,059,156
Total liabilities
$1,743,055
$3,287,000
$1,359,728
$986,499
$1,432,506
Other
Headcount
—
11
11
—
12
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$78.4M
post-money
PHIZZLE Common Stock 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $141.9K / $5MInvestors 176Post-money $78.4M
Reg CF annual-report compliance
Not requiredFewer than 300 holders of record
Filed 2 of 4 annual reports (FY2022–FY2025)
176 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001343322Share price $0.40
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.